FB Pixel no scriptKrASIA | Decoding China's tech and business pulse
MENU
KrASIA

Features

With fresh funding, JQ Industries bets on fiber sensors to give machines a sense of touch

4 mins read

Pulses

China’s top drugmaker jumps on HK listing

just now
Fortune
Shares of China’s largest drugmaker, Hengrui Pharmaceuticals, opened 29% higher in its Hong Kong debut after raising HKD 9.9 billion, making it one of the year’s largest listings. The proceeds will support its global R&D in oncology, cardiometabolic, and neurological drugs, as the firm seeks its first overseas approvals. The IPO adds momentum to Hong Kong’s rebounding capital markets.
See All

Icon for Editor’s PicksEditor’s Picks

Insights

Beneath the bureaucracy: How state capital made (and remade) China’s venture ecosystem

A new model of state capital is taking root in China—one that’s redefining how venture capital works, from funding mechanics to policy alignment.

30 mins read
  • Features

    ByteDance launches Coze, its new AI agent platform, in beta

    8 mins read

Venture RoundupVenture Roundup